Rat renal interstitial fibroblasts affect the Th1/Th2 profile in vitro

Renal Failure

Volumn 33, Issue 10, 2011, Pages 1025-1031

  Xing, Zhi Zhi ^a   Zhang, Dong Liang ^a   Li, Hai ^a   Chen, Hui ^a   Jia, Ji Dong ^a   Wang, Zhi Gang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Fibroblasts; Galectin 9; Renal interstitial; Th1 cells; Th2 cells

Indexed keywords

ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL INTERSTITIAL FIBROBLAST; T LYMPHOCYTE SUBPOPULATION; TH1 TH2 BALANCE; WESTERN BLOTTING;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLASTS; GALECTINS; KIDNEY; RATS; TH1 CELLS; TH2 CELLS;

EID: 80054893716     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.618924     Document Type: Article

References (25)

1. Harris RC, Neilson EG. Toward a unified theory of renal progression. Annu Rev Med. 2006;57:365-380. (Pubitemid 43261996)
2. Bohle A, Strutz F, Muller GA. On the pathogenesis of chronic renal failure in primary glomerulopathies: A view from the interstitium. Exp Nephrol. 1994;2:205-210. (Pubitemid 24201686)
3. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2011. (in press).
4. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens. 2004;13:279-284. (Pubitemid 38582300)
5. Marra F, Aleffi S, Galastri S, Provenzano A.Mononuclear cells in liver fibrosis. Semin Immunopathol. 2009;31:345-358.
6. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199-210. (Pubitemid 351160157)
7. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol. 2008;83: 1323-1333. (Pubitemid 351960310)
8. Parsonage G, Falciani F, Burman A, et al. Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Hemost. 2003;90:688-697. (Pubitemid 37287637)
9. Buckley CD, Amft N, Bradfield PF, et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol. 2000;165:3423-3429.
10. Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6:1245-1252. (Pubitemid 43045636)
11. Asakura H, Kashio Y, Nakamura K, et al. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol. 2002;169:5912-5918. (Pubitemid 35291697)
12. Igawa K, Satoh T, Hirashima M, Yokozeki H. Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: Possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation. Allergy. 2006;61:1385-1391. (Pubitemid 44665300)
13. Takahashi Y, Fukusato T, Kobayashi Y, et al. High expression of eosinophil chemoattractant ecalectin/galectin-9 in druginduced liver injury. Liver Int. 2006;26:106-115.
14. Grimwood L, Masterson R. Propagation and culture of renal fibroblasts. Methods Mol Biol. 2009;466:25-37.
15. Caraher EM, Parenteau M, Gruber H, Scott FW. Flow cytometric analysis of intracellular IFN-gamma, IL-4 and IL-10 in CD3(+)4(+) T-cells from rat spleen. J Immunol Methods. 2000;244:29-40.
16. Ku BM, Ryu HW, Lee YK, et al. 4-Acetoamido-4- hydroxychalcone, a chalcone derivative, inhibits glioma growth and invasion through regulation of the tropomyosin 1 gene. Biochem Biophys Res Commun. 2010;402:525-530.
17. Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res. 1999;250: 273-283. (Pubitemid 29367440)
18. Pilling D, Akbar AN, Girdlestone J, et al. Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol. 1999;29:1041-1050. (Pubitemid 29119085)
19. Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chin Med J (Engl). 2010;123: 942-948.
20. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 1999;56:2116-2127. (Pubitemid 30004740)
21. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132. (Pubitemid 41541790)
22. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-1141. (Pubitemid 41541791)
23. McGaha TL, Bona CA. Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma. Autoimmun Rev. 2002;1:174-181. (Pubitemid 38340269)
24. Guicciardi ME, Gores GJ. Apoptosis as a mechanism for liver disease progression. Semin Liver Dis. 2010;30:402-410.
25. Imaizumi T, Kumagai M, Sasaki N, et al. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol. 2002;72:486-491.